Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia
Withdrawn
- Conditions
- Endotracheal IntubationCOVID-19
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2020-07-20
- Lead Sponsor
- Tongji Hospital
- Registration Number
- NCT04298814
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
Early Phase 1
- Conditions
- COVID-19Recombinant Human Interferon α1β
- Interventions
- Drug: Recombinant human interferon α1β
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 328
- Registration Number
- NCT04293887
The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 550
- Registration Number
- NCT04291053
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04263402
- Locations
- 🇨🇳
Department and Institute of Infectious Disease, Wuhan, Hubei, China
A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
Phase 3
- Conditions
- 2019-nCoV Pneumonia
- Interventions
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04261270
- Locations
- 🇨🇳
Department and Institute of Infectious Disease, Wuhan, Hubei, China
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
Phase 4
- Conditions
- 2019-nCoV
- Interventions
- Drug: Abidol hydrochlorideDrug: Abidol Hydrochloride combined with Interferon atomization
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04254874
- Locations
- 🇨🇳
Department and Institute of Infectious Disease, Wuhan, Hubei, China
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
Phase 4
- Conditions
- 2019-nCoV
- Interventions
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT04255017
- Locations
- 🇨🇳
Department and Institute of Infectious Disease, Wuhan, Hubei, China
Perfusion Index as an Objective Measure for Supraclavicular Brachial Plexus Block in Pediatric Patients
Completed
- Conditions
- Supraclavicular Brachial Plexus Block
- Interventions
- Device: perfusion index
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 104
- Registration Number
- NCT04216823
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study
Active, not recruiting
- Conditions
- Endometrial CancerCervical CancerOvarian CancerGynecologic Cancer
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT04214964
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
Not Applicable
Not yet recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Diagnostic Test: Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT04214782
© Copyright 2025. All Rights Reserved by MedPath